{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:52:51Z","timestamp":1789735971537,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01613-1","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T23:46:29Z","timestamp":1748043989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["New hope and promise with CRISPR-Cas9 technology for the treatment of HIV"],"prefix":"10.1007","volume":"25","author":[{"given":"Hesham M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam Taher","family":"Almagharbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranya Mohammed","family":"Elmagzoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"7785","key":"1613_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV et al (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149\u2013157","journal-title":"Nature"},{"issue":"32","key":"1613_CR2","doi-asserted-by":"crossref","first-page":"23104","DOI":"10.1074\/jbc.M703485200","volume":"282","author":"AK Bellamy-McIntyre","year":"2007","unstructured":"Bellamy-McIntyre AK et al (2007) Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion. J Biol Chem 282(32):23104\u201323116","journal-title":"J Biol Chem"},{"issue":"2","key":"1613_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/crispr.2017.0024","volume":"1","author":"C Brokowski","year":"2018","unstructured":"Brokowski C (2018) Do CRISPR Germline Ethics Statements Cut It? Crispr J 1(2):115\u2013125","journal-title":"Crispr J"},{"issue":"11","key":"1613_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jgg.2018.10.001","volume":"45","author":"L Cai","year":"2018","unstructured":"Cai L, Zheng LA, He L (2018) The forty years of medical genetics in China. J Genet Genomics 45(11):569\u2013582","journal-title":"J Genet Genomics"},{"issue":"4","key":"1613_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10142-024-01399-8","volume":"24","author":"Y Chen","year":"2024","unstructured":"Chen Y et al (2024) CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer. Funct Integr Genomics 24(4):125","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"1613_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","volume":"31","author":"SW Cho","year":"2013","unstructured":"Cho SW et al (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31(3):230\u2013232","journal-title":"Nat Biotechnol"},{"key":"1613_CR7","first-page":"2015","volume":"22","author":"D Cyranoski","year":"2015","unstructured":"Cyranoski D, Reardon S (2015) Chinese scientists genetically modify human embryos. Nature News 22:2015","journal-title":"Nature News"},{"key":"1613_CR8","doi-asserted-by":"crossref","unstructured":"de la Mora L, Mallolas J, and Ambrosioni J, (2024) Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review. Medicina Cl\u00ednica (English Edition)","DOI":"10.1016\/j.medcle.2023.12.010"},{"issue":"1","key":"1613_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/v13010024","volume":"13","author":"K D\u00e9saulniers","year":"2020","unstructured":"D\u00e9saulniers K et al (2020) Editing of the TRIM5 gene decreases the permissiveness of human T lymphocytic cells to HIV-1. Viruses 13(1):24","journal-title":"Viruses"},{"issue":"8","key":"1613_CR10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/cr.2014.87","volume":"24","author":"J Duan","year":"2014","unstructured":"Duan J et al (2014) Genome-wide identification of CRISPR\/Cas9 off-targets in human genome. Cell Res 24(8):1009\u20131012","journal-title":"Cell Res"},{"issue":"1","key":"1613_CR11","doi-asserted-by":"crossref","first-page":"e0191709","DOI":"10.1371\/journal.pone.0191709","volume":"13","author":"C Dufour","year":"2018","unstructured":"Dufour C et al (2018) Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1. PLoS ONE 13(1):e0191709","journal-title":"PLoS ONE"},{"issue":"1","key":"1613_CR12","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","volume":"3","author":"H Ebina","year":"2013","unstructured":"Ebina H et al (2013) Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3(1):2510","journal-title":"Sci Rep"},{"key":"1613_CR13","doi-asserted-by":"publisher","unstructured":"Esvelt KM, Smidler AL, Catteruccia F, Church GM (2014) Concerning RNA-guided gene drives for the\u00a0alteration of wild populations. eLife 3:e03401. https:\/\/doi.org\/10.7554\/eLife.03401","DOI":"10.7554\/eLife.03401"},{"issue":"12","key":"1613_CR14","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1073\/pnas.87.12.4650","volume":"87","author":"EO Freed","year":"1990","unstructured":"Freed EO, Myers DJ, Risser R (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci 87(12):4650\u20134654","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1613_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y et al (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3):279\u2013284","journal-title":"Nat Biotechnol"},{"issue":"10","key":"1613_CR16","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","volume":"48","author":"Z Gao","year":"2020","unstructured":"Gao Z et al (2020) Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA. Nucleic Acids Res 48(10):5527\u20135539","journal-title":"Nucleic Acids Res"},{"issue":"7681","key":"1613_CR17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM et al (2017) Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage. Nature 551(7681):464\u2013471","journal-title":"Nature"},{"issue":"5","key":"1613_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/crispr.2019.0038","volume":"2","author":"HT Greely","year":"2019","unstructured":"Greely HT (2019) Human Germline Genome Editing: An Assessment. Crispr J 2(5):253\u2013265","journal-title":"Crispr J"},{"issue":"7","key":"1613_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41587-020-0535-y","volume":"38","author":"J Gr\u00fcnewald","year":"2020","unstructured":"Gr\u00fcnewald J et al (2020) A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing. Nat Biotechnol 38(7):861\u2013864","journal-title":"Nat Biotechnol"},{"issue":"5","key":"1613_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/crispr.2019.0042","volume":"2","author":"J Halpern","year":"2019","unstructured":"Halpern J et al (2019) Societal and Ethical Impacts of Germline Genome Editing: How Can We Secure Human Rights? Crispr J 2(5):293\u2013298","journal-title":"Crispr J"},{"issue":"3","key":"1613_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bfgp\/elz021","volume":"19","author":"E Herrera-Carrillo","year":"2020","unstructured":"Herrera-Carrillo E, Gao Z, Berkhout B (2020) CRISPR therapy towards an HIV cure. Brief Funct Genomics 19(3):201\u2013208","journal-title":"Brief Funct Genomics"},{"key":"1613_CR22","doi-asserted-by":"crossref","first-page":"103678","DOI":"10.1016\/j.ebiom.2021.103678","volume":"73","author":"J Herskovitz","year":"2021","unstructured":"Herskovitz J et al (2021) CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination. EBioMedicine 73:103678","journal-title":"EBioMedicine"},{"issue":"4","key":"1613_CR23","first-page":"60","volume":"3","author":"A Hima Bindu","year":"2011","unstructured":"Hima Bindu A, Naga Anusha P (2011) Adverse effects of highly active anti-retroviral therapy (HAART). J Antivir Antiretrovir 3(4):60\u201364","journal-title":"J Antivir Antiretrovir"},{"issue":"1","key":"1613_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/life14010104","volume":"14","author":"J Hokello","year":"2024","unstructured":"Hokello J et al (2024) New insights into HIV life cycle, Th1\/Th2 shift during HIV infection and preferential virus infection of Th2 cells: Implications of early HIV treatment initiation and care. Life 14(1):104","journal-title":"Life"},{"issue":"1","key":"1613_CR25","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1038\/srep15577","volume":"5","author":"P Hou","year":"2015","unstructured":"Hou P et al (2015) Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection. Sci Rep 5(1):15577","journal-title":"Sci Rep"},{"issue":"1","key":"1613_CR26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41467-021-21337-7","volume":"12","author":"JY Hsu","year":"2021","unstructured":"Hsu JY et al (2021) PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nat Commun 12(1):1034","journal-title":"Nat Commun"},{"issue":"31","key":"1613_CR27","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"W Hu","year":"2014","unstructured":"Hu W et al (2014) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci 111(31):11461\u201311466","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"1613_CR28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.celrep.2016.09.080","volume":"17","author":"JF Hultquist","year":"2016","unstructured":"Hultquist JF et al (2016) A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells. Cell Rep 17(5):1438\u20131452","journal-title":"Cell Rep"},{"issue":"6096","key":"1613_CR29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"issue":"2","key":"1613_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","volume":"39","author":"HK Kim","year":"2021","unstructured":"Kim HK et al (2021) Predicting the efficiency of prime editing guide RNAs in human cells. Nat Biotechnol 39(2):198\u2013206","journal-title":"Nat Biotechnol"},{"key":"1613_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jbiotec.2018.08.007","volume":"284","author":"ML Kimberland","year":"2018","unstructured":"Kimberland ML et al (2018) Strategies for controlling CRISPR\/Cas9 off-target effects and biological variations in mammalian genome editing experiments. J Biotechnol 284:91\u2013101","journal-title":"J Biotechnol"},{"issue":"7603","key":"1613_CR32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC et al (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533(7603):420\u2013424","journal-title":"Nature"},{"issue":"1","key":"1613_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12981-017-0157-8","volume":"14","author":"A Kwarteng","year":"2017","unstructured":"Kwarteng A, Ahuno ST, Kwakye-Nuako G (2017) The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 14(1):32","journal-title":"AIDS Res Ther"},{"issue":"12","key":"1613_CR34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/1440-1681.13151","volume":"46","author":"U Laila","year":"2019","unstructured":"Laila U et al (2019) Role of medicinal plants in HIV\/AIDS therapy. Clin Exp Pharmacol Physiol 46(12):1063\u20131073","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1613_CR35","doi-asserted-by":"crossref","first-page":"41968","DOI":"10.1038\/srep41968","volume":"7","author":"RJ Lebbink","year":"2017","unstructured":"Lebbink RJ et al (2017) A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci Rep 7(1):41968","journal-title":"Sci Rep"},{"issue":"7554","key":"1613_CR36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/522020a","volume":"522","author":"H Ledford","year":"2015","unstructured":"Ledford H (2015) CRISPR, the disruptor. Nature 522(7554):20\u201324","journal-title":"Nature"},{"issue":"6","key":"1613_CR37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.gpb.2022.12.006","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y (2022) A beloved bioinformatician buddy\u2014In memory of Professor Weimin Zhu. Genom Proteom Bioinform 20(6):1037\u20131039","journal-title":"Genom Proteom Bioinform"},{"issue":"8","key":"1613_CR38","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","volume":"96","author":"C Li","year":"2015","unstructured":"Li C et al (2015) Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9. J Gen Virol 96(8):2381\u20132393","journal-title":"J Gen Virol"},{"issue":"1","key":"1613_CR39","doi-asserted-by":"crossref","first-page":"e1007498","DOI":"10.1371\/journal.ppat.1007498","volume":"15","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency. PLoS Pathog 15(1):e1007498","journal-title":"PLoS Pathog"},{"issue":"5","key":"1613_CR40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","volume":"6","author":"P Liang","year":"2015","unstructured":"Liang P et al (2015) CRISPR\/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363\u2013372","journal-title":"Protein Cell"},{"issue":"1","key":"1613_CR41","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","volume":"6","author":"H-K Liao","year":"2015","unstructured":"Liao H-K et al (2015) Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat Commun 6(1):6413","journal-title":"Nat Commun"},{"issue":"5","key":"1613_CR42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41587-020-0455-x","volume":"38","author":"Q Lin","year":"2020","unstructured":"Lin Q et al (2020) Prime genome editing in rice and wheat. Nat Biotechnol 38(5):582\u2013585","journal-title":"Nat Biotechnol"},{"key":"1613_CR43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12033-014-9768-7","volume":"56","author":"Y Liu","year":"2014","unstructured":"Liu Y et al (2014) A novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner. Mol Biotechnol 56:890\u2013902","journal-title":"Mol Biotechnol"},{"issue":"1","key":"1613_CR44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2016.12.031","volume":"168","author":"L Liu","year":"2017","unstructured":"Liu L et al (2017) Two distant catalytic sites are responsible for C2c2 RNase activities. Cell 168(1):121-134. e12","journal-title":"Cell"},{"issue":"1","key":"1613_CR45","first-page":"1","volume":"8","author":"S Liu","year":"2018","unstructured":"Liu S et al (2018) HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies. Sci Rep 8(1):1\u201311","journal-title":"Sci Rep"},{"key":"1613_CR46","first-page":"1","volume":"10","author":"Z Liu","year":"2020","unstructured":"Liu Z et al (2020) Genome editing of CCR5 by AsCpf1 renders CD4+ T cells resistance to HIV-1 infection. Cell Biosci 10:1\u201313","journal-title":"Cell Biosci"},{"key":"1613_CR47","doi-asserted-by":"publisher","unstructured":"Lu W et al., (2019) The polar region of the HIV-1 envelope protein determines viral fusion and infectivity by stabilizing the gp120-gp41 association. J Virol. 93(7). https:\/\/doi.org\/10.1128\/jvi.02128-18","DOI":"10.1128\/jvi.02128-18"},{"issue":"6121","key":"1613_CR48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P et al (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823\u2013826","journal-title":"Science"},{"issue":"1","key":"1613_CR49","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41467-020-19821-7","volume":"11","author":"P Mancuso","year":"2020","unstructured":"Mancuso P et al (2020) CRISPR based editing of SIV proviral DNA in ART treated non-human primates. Nat Commun 11(1):6065","journal-title":"Nat Commun"},{"issue":"5","key":"1613_CR50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","volume":"15","author":"PK Mandal","year":"2014","unstructured":"Mandal PK et al (2014) Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9. Cell Stem Cell 15(5):643\u2013652","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1613_CR51","first-page":"23","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, High KA (2013) Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood, J Am Soc Hematol 122(1):23\u201336","journal-title":"Blood, J Am Soc Hematol"},{"issue":"9","key":"1613_CR52","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/v13091850","volume":"13","author":"H Nguyen","year":"2021","unstructured":"Nguyen H et al (2021) Efficient inhibition of HIV using CRISPR\/Cas13d nuclease system. Viruses 13(9):1850","journal-title":"Viruses"},{"issue":"10","key":"1613_CR53","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/v12101154","volume":"12","author":"A Olson","year":"2020","unstructured":"Olson A et al (2020) Targeted chromatinization and repression of HIV-1 provirus transcription with repurposed CRISPR\/Cas9. Viruses 12(10):1154","journal-title":"Viruses"},{"issue":"11","key":"1613_CR54","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/v12111223","volume":"12","author":"Y Ophinni","year":"2020","unstructured":"Ophinni Y et al (2020) Multiplexed tat-targeting CRISPR-cas9 protects T cells from acute HIV-1 infection with inhibition of viral escape. Viruses 12(11):1223","journal-title":"Viruses"},{"issue":"2","key":"1613_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajhg.2017.06.012","volume":"101","author":"KE Ormond","year":"2017","unstructured":"Ormond KE et al (2017) Human Germline Genome Editing. Am J Hum Genet 101(2):167\u2013176","journal-title":"Am J Hum Genet"},{"issue":"8","key":"1613_CR56","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/1574888X13666180613081443","volume":"13","author":"SN Patmanathan","year":"2018","unstructured":"Patmanathan SN et al (2018) CRISPR\/Cas9 in Stem Cell Research: Current Application and Future Perspective. Curr Stem Cell Res Ther 13(8):632\u2013644","journal-title":"Curr Stem Cell Res Ther"},{"issue":"2","key":"1613_CR57","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/curroncol30020152","volume":"30","author":"AA Rabaan","year":"2023","unstructured":"Rabaan AA et al (2023) Application of CRISPR\/Cas9 Technology in Cancer Treatment: A Future Direction. Curr Oncol 30(2):1954\u20131976","journal-title":"Curr Oncol"},{"issue":"5","key":"1613_CR58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10142-024-01455-3","volume":"24","author":"J Rajanathadurai","year":"2024","unstructured":"Rajanathadurai J, Perumal E, Sindya J (2024) Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects. Funct Integr Genomics 24(5):164","journal-title":"Funct Integr Genomics"},{"issue":"6","key":"1613_CR59","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran FA et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380\u20131389","journal-title":"Cell"},{"key":"1613_CR60","doi-asserted-by":"publisher","unstructured":"Rodriguez E (2016) Ethical issues in genome editing using Crispr\/Cas9 system. J Clin Res Bioethics 7(2). https:\/\/doi.org\/10.4172\/2155-9627.1000266","DOI":"10.4172\/2155-9627.1000266"},{"issue":"7","key":"1613_CR61","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41587-020-0509-0","volume":"38","author":"RC Sakata","year":"2020","unstructured":"Sakata RC et al (2020) Base editors for simultaneous introduction of C-to-T and A-to-G mutations. Nat Biotechnol 38(7):865\u2013869","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1613_CR62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cell.2023.12.002","volume":"187","author":"KO Saunders","year":"2024","unstructured":"Saunders KO et al (2024) Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques. Cell 187(1):79\u20139424","journal-title":"Cell"},{"issue":"11","key":"1613_CR63","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","volume":"9","author":"E Sen\u00eds","year":"2014","unstructured":"Sen\u00eds E et al (2014) CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. Biotechnol J 9(11):1402\u20131412","journal-title":"Biotechnol J"},{"issue":"2","key":"1613_CR64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/cid\/ciw683","volume":"64","author":"I Sereti","year":"2017","unstructured":"Sereti I et al (2017) Editor\u2019s choice: persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin Infect Dis Off Publc Infect Dis Soc Am 64(2):124","journal-title":"Clin Infect Dis Off Publc Infect Dis Soc Am"},{"issue":"2","key":"1613_CR65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.virusres.2012.06.015","volume":"169","author":"RP Smyth","year":"2012","unstructured":"Smyth RP, Davenport MP, Mak J (2012) The origin of genetic diversity in HIV-1. Virus Res 169(2):415\u2013429","journal-title":"Virus Res"},{"issue":"10","key":"1613_CR66","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","volume":"370","author":"P Tebas","year":"2014","unstructured":"Tebas P et al (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370(10):901\u2013910","journal-title":"N Engl J Med"},{"issue":"6","key":"1613_CR67","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","volume":"14","author":"O ter Brake","year":"2006","unstructured":"ter Brake O et al (2006) Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 14(6):883\u2013892","journal-title":"Mol Ther"},{"issue":"3","key":"1613_CR68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mt.6300382","volume":"16","author":"O ter Brake","year":"2008","unstructured":"ter Brake O et al (2008) Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 16(3):557\u2013564","journal-title":"Mol Ther"},{"issue":"6","key":"1613_CR69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.2908","volume":"32","author":"SQ Tsai","year":"2014","unstructured":"Tsai SQ et al (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32(6):569\u2013576","journal-title":"Nat Biotechnol"},{"issue":"7","key":"1613_CR70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1348-0421.12395","volume":"60","author":"S Ueda","year":"2016","unstructured":"Ueda S et al (2016) Anti-HIV-1 potency of the CRISPR\/Cas9 system insufficient to fully inhibit viral replication. Microbiol Immunol 60(7):483\u2013496","journal-title":"Microbiol Immunol"},{"issue":"6","key":"1613_CR71","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JVI.02035-07","volume":"82","author":"KJ von Eije","year":"2008","unstructured":"von Eije KJ, ter Brake O, Berkhout B (2008) Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 82(6):2895\u20132903","journal-title":"J Virol"},{"issue":"6","key":"1613_CR72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jgm.1329","volume":"11","author":"KJ von Eije","year":"2009","unstructured":"von Eije KJ, ter Brake O, Berkhout B (2009) Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs. J Gene Med 11(6):459\u2013467","journal-title":"J Gene Med"},{"issue":"12","key":"1613_CR73","doi-asserted-by":"crossref","first-page":"e115987","DOI":"10.1371\/journal.pone.0115987","volume":"9","author":"W Wang","year":"2014","unstructured":"Wang W et al (2014) CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection. PLoS ONE 9(12):e115987","journal-title":"PLoS ONE"},{"issue":"2","key":"1613_CR74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nbt.3127","volume":"33","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33(2):175\u2013178","journal-title":"Nat Biotechnol"},{"key":"1613_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-017-0375-0","volume":"14","author":"Q Wang","year":"2017","unstructured":"Wang Q et al (2017) Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection. Retrovirology 14:1\u201312","journal-title":"Retrovirology"},{"key":"1613_CR76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2018.04.002","volume":"250","author":"Q Wang","year":"2018","unstructured":"Wang Q et al (2018) Genome scale screening identification of SaCas9\/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection. Virus Res 250:21\u201330","journal-title":"Virus Res"},{"key":"1613_CR77","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3389\/fimmu.2017.01616","volume":"8","author":"DAV Weatherley","year":"2017","unstructured":"Weatherley DAV, Boswell MT, Rowland-Jones SL (2017) Targeting TRIM5\u03b1 in HIV Cure Strategies for the CRISPR-Cas9 Era. Front Immunol 8:1616","journal-title":"Front Immunol"},{"key":"1613_CR78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","volume":"9","author":"Q Xiao","year":"2019","unstructured":"Xiao Q, Guo D, Chen S (2019) Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy. Front Cell Infect Microbiol 9:69","journal-title":"Front Cell Infect Microbiol"},{"key":"1613_CR79","first-page":"1","volume":"16","author":"Q Xiao","year":"2019","unstructured":"Xiao Q et al (2019) CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem\/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice. Retrovirology 16:1\u201317","journal-title":"Retrovirology"},{"issue":"8","key":"1613_CR80","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","volume":"25","author":"L Xu","year":"2017","unstructured":"Xu L et al (2017) CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo. Mol Ther 25(8):1782\u20131789","journal-title":"Mol Ther"},{"issue":"13","key":"1613_CR81","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","volume":"381","author":"L Xu","year":"2019","unstructured":"Xu L et al (2019) CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia. N Engl J Med 381(13):1240\u20131247","journal-title":"N Engl J Med"},{"issue":"2","key":"1613_CR82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10142-023-01117-w","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang B (2023) A review on CRISPR\/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment. Funct Integr Genomics 23(2):182","journal-title":"Funct Integr Genomics"},{"issue":"26","key":"1613_CR83","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","volume":"111","author":"L Ye","year":"2014","unstructured":"Ye L et al (2014) Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5\u039432 mutation confers resistance to HIV infection. Proc Natl Acad Sci 111(26):9591\u20139596","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"1613_CR84","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","volume":"25","author":"C Yin","year":"2017","unstructured":"Yin C et al (2017) In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol Ther 25(5):1168\u20131186","journal-title":"Mol Ther"},{"key":"1613_CR85","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1038\/ncomms5240","volume":"5","author":"K Yoshimi","year":"2014","unstructured":"Yoshimi K et al (2014) Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform. Nat Commun 5:4240","journal-title":"Nat Commun"},{"issue":"3","key":"1613_CR86","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B et al (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163(3):759\u2013771","journal-title":"Cell"},{"issue":"R1","key":"1613_CR87","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","volume":"23","author":"F Zhang","year":"2014","unstructured":"Zhang F, Wen Y, Guo X (2014) CRISPR\/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet 23(R1):R40\u2013R46","journal-title":"Hum Mol Genet"},{"key":"1613_CR88","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jastp.2018.01.023","volume":"169","author":"Y Zhang","year":"2018","unstructured":"Zhang Y et al (2018) Storm-time variations of atomic nitrogen 149.3 nm emission. J Atmos Solar-Terrest Phys 169:78\u201382","journal-title":"J Atmos Solar-Terrest Phys"},{"issue":"1","key":"1613_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virs.2022.01.017","volume":"37","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Hou W, Chen S (2022) Updates on CRISPR-based gene editing in HIV-1\/AIDS therapy. Virologica Sinica 37(1):1\u201310","journal-title":"Virologica Sinica"},{"key":"1613_CR90","first-page":"1","volume":"12","author":"W Zhu","year":"2015","unstructured":"Zhu W et al (2015) The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology 12:1\u20137","journal-title":"Retrovirology"},{"issue":"5","key":"1613_CR91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10142-024-01425-9","volume":"24","author":"A Zubair","year":"2024","unstructured":"Zubair A et al (2024) Clinical trials and recent progress in HIV vaccine development. Funct Integr Genomics 24(5):143","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"1613_CR92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10989-025-10702-5","volume":"31","author":"A Zubair","year":"2025","unstructured":"Zubair A, Ali M, Akhtar N (2025) HIV-1 Nef Gene Characterization and Subtype Analysis in Pakistan: A Molecular Docking Approach with Mastoparan-L Peptide. Int J Pept Res Ther 31(3):46","journal-title":"Int J Pept Res Ther"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01613-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01613-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01613-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:08:23Z","timestamp":1769155703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01613-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01613-1","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical consideration.\n                      No underlying data was collected or produced in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials"}},{"value":"The authors declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"108"}}